Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial (Q42994283)
Jump to navigation
Jump to search
scientific article published in July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial |
scientific article published in July 2010 |
Statements
1 reference
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial (English)
1 reference
Hartmut Döhner
1 reference
Thorsten Zenz
1 reference
Michael Hallek
1 reference
Peter Dreger
1 reference
Matthias Ritgen
1 reference
Sebastian Böttcher
1 reference
Raymonde Busch
1 reference
Sascha Dietrich
1 reference
Donald Bunjes
1 reference
Sandra Cohen
1 reference
Jörg Schubert
1 reference
Ute Hegenbart
1 reference
Dietrich Beelen
1 reference
Matthias Zeis
1 reference
Michael Stadler
1 reference
Justin Hasenkamp
1 reference
Lutz Uharek
1 reference
Christof Scheid
1 reference
Andreas Humpe
1 reference
Dirk Winkler
1 reference
Michael Kneba
1 reference
Norbert Schmitz
1 reference
German CLL Study Group
1 reference
1 July 2010
1 reference
Identifiers
1 reference